Expression and localization of endothelin-converting enzyme-1 in human prostate cancer

Experimental Biology and Medicine

Volumn 231, Issue 6, 2006, Pages 1106-1110

  Dawson, Louise A ^a   Maitland, Norman J ^b   Berry, Paul ^b   Turner, Anthony J ^a   Usmani, Badar A ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Endothelin; Endothelin converting enzyme (ECE); Isoforms; Metallopeptidases; Prostate cancer; Stromal epithelial interactions

Indexed keywords

ENDOTHELIN CONVERTING ENZYME; MESSENGER RNA;

CANCER CELL; CELLULAR DISTRIBUTION; CONFERENCE PAPER; IMMUNOREACTIVITY; PROSTATE CANCER; PROTEIN EXPRESSION;

ASPARTIC ENDOPEPTIDASES; CELL LINE, TRANSFORMED; CELL LINE, TUMOR; EPITHELIAL CELLS; HUMANS; ISOENZYMES; MALE; METALLOENDOPEPTIDASES; PROSTATIC NEOPLASMS; RNA, MESSENGER; STROMAL CELLS; TUMOR CELLS, CULTURED;

EID: 33744906041     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (23)

1. Kirby RS, Brawer MK. Denis L. Prostate Cancer (3rd ed). Oxford: Health Press, p52, 2001.
2. Bologna M, Festuccia C, Muzi P, Biordi L, Ciomei M. Bombesin stimulates growth of human prostatic cancer cells in vitro. Cancer 63(9):1714-1720, 1989.
3. Papandreou CN, Usmani B, Geng Y, Bogenrieder T, Freeman R, Wilk S, Finstad CL, Reuter VE, Powell CT, Scheinberg D, Magill C, Scher HI, Albino AP, Nanus DM. Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med 4(1):50-57, 1998.
4. Nelson, JB, Hedican SP, George DJ, Reddi AH, Piantadosi S, Eisenberger MA, Simons JW. Identification of endothelin-1 in the pathophysiology of metastatic adenocarcinoma of the prostate. Nat Med 1:944-949, 1995.
5. Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane bound, phosphoramidin-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270:15262-15268, 1995.
6. Schweizer A, Valdenaire O, Nelbock P, Deuschle U, Edwards J, Stumpf JG, Loffler BM. Human endothelin-converting enzyme (ECE-1): three isoforms with distinct subcellular localizations. Biochem J 328: 871-877, 1997.
7. Valdenaire O, Lepailleur-Enouf D, Egidy G, Thouard A, Barret A, Vranckx R, Tougard C Michel, JB. A fourth isoform of endothelin-converting enzyme (ECE-1) is generated from an additional promoter: molecular cloning and characterization. Eur J Biochem 264: 341-349, 1999.
8. Muller L, Barret A, Etienne E, Meidan R, Valdenaire O, Corvol P, Tougard C. Heterodimerization of endothelin-converting enzyme-1 isoforms regulates the subcellular distribution of this metalloprotease. J Biol Chem 278:545-555, 2003.
9. Dawson LA, Maitland NJ, Turner AJ, Usmani BA. Stromal-epithelial interactions influence prostate cancer cell invasion by altering the balance of metallopeptidase expression. Br J Cancer, 90:1577-1582, 2004.
10. Usmani BA, Harden B, Maitland NJ, Turner AJ. Differential expression of neutral endopeptidase-24.11 (neprilysin) and endothelin-converting enzyme in human prostate cancer cell lines. Clin Sci (London) 103: 314S-317S, 2002.
11. Egidy G, Juillerat-Jeanneret L, Jeannin JF, Korth P, Bosman FT, Pinet F. Modulation of human colon tumor-stromal interactions by the endothelin system. Am J Path 157(6):1863-1874, 2000.
12. Erbel LP, Valdenaire O, Saintgiorgio V Jeannin J-F, Juillerat-Jeanneret L. Endothelin receptor blockade potentiates Fas-L induced apoptosis in rat colon carcinoma cells. Int J Cancer 86: 82-187, 2000.
13. Brown CD, Barnes K, Turner AJ. Anti-peptide antibodies specific to rat endothelin-converting enzyme-1 isoforms reveal isoform localisation and expression. FEBS Lett 424(3):183-187, 1998.
14. Lang SH, Stower M, Maitland NJ. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Br J Cancer 82:990-997, 2000.
15. Maitland NJ, Macintosh CA, Hall J, Sharrard M, Quinn G, Lang S. In vitro models to study cellular differentiation and function in human prostate cancers. Radiation Res 155:13-142, 2001.
16. Arun B, Kilic G, Ashfaq R, Saboorian HM, Gokaslan T. Endothelin- converting enzyme-1 expression in endometrial adenocarcinomas. Cancer Invest 19(8):779-782, 2001.
17. Ahmed SI, Thompson J, Coulson JM, Woll PJ. Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Resp Cell Mol Biol 22:422-431, 2000.
18. Jafri F, Ergul A. Nuclear localization of endothelin-converting enzyme-1. Arterio Thromb Vasc Biol 23:1-5, 2003.
19. Takahashi M, Fukuda K, Shimada K, Barnes K, Turner AJ, Ikeda M, Koike H, Yamamoto Y, Tanzawa K. Localisation of rat endothelin-converting enzyme to vascular endothelial cells and some secretory cells. Biochem J 311:657-665, 1995.
20. Barnes K, Shimada K, Takahashi M, Tanzawa K, Turner AJ. Metallopeptidase inhibitors induce an up-regulation of endothelin-converting enzyme levels and its redistribution from the plasma membrane to an intracellular compartment. J Cell Sci, 109:919-928, 1996.
21. Russell FD, Skepper JN, Davenport AP. Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer. Circ Res 83(3):314-321, 1998.
22. Ventura S, Salamoussa A. Big endothelin-1 but not endothelin-1 is present in the smooth muscle stroma of the prostate gland of the rat. J Anat 200:153-158, 2002.
23. Barnes K, Turner AJ. Endothelin converting enzyme is located on alpha-actin filaments in smooth muscle cells. Cardiovasc Res 42:814-822, 1999.